BioSpace News Archive

The Honourable Kirsty Duncan, Minister of Science and Sport, will make a funding announcement that will help research centers in diverse sectors, including health care, bring their innovative solutions to market.

Bayer today released a Fact Check of The Bleeding Edge, which premieres on Netflix on July 27, devotes significant time to Essure, the only FDA-approved non-incisional form of permanent birth control, and is now the subject of media coverage by The New York Times, CBS News, and others.

MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced that senior management will participate in a fireside chat at the RBC Capital Markets’ 2018 Healthcare Conference on Wednesday, February 21, 2018, at 8:30 a.m. ET in New York, NY.

bluebird bio, Inc. (Nasdaq: BLUE) today announced the closing of its previously announced underwritten public offering of 3,892,308 shares of its common stock, including 507,692 shares of common stock sold pursuant to the underwriters’ full exercise of their option to purchase additional shares, at a public offering price of $162.50 per share.

Says Legislation Will Provide More Compassionate, Cost-Effective Care for America’s Children

Beacon Point brings quality-care to the heart of the epidemic in Philadelphia

PERSERIS is the first once-monthly subcutaneous risperidone-containing long-acting injectable

Innovative and effective Knowledge Management (KM) can be a significant driver of growth, performance excellence and agility.

Health Net of California, Inc., one of California’s largest health care service plans, announced today that it is providing assistance to members of Riverside County affected by the Cranston Fire.

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until September 17, 2018 to file lead plaintiff applications in a securities class action lawsuit against ACADIA Pharmaceuticals Inc. (NasdaqGS: ACAD), if they purchased the Company’s securities between April 29, 2016 and July 9, 2018